Somalogic s1

Author: claq

August undefined, 2024

WebJan 5, 2024 · Partnership will Accelerate Next-Generation Sequencing into Fastest-Growing Area of Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina's … WebSomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2024 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. History.

SomaLogic - Crunchbase Company Profile & Funding

WebOct 1, 2024 · Somalogic, Inc. (SLGC) SEC Filing S-1 IPO Report. Ticker: SLGC CIK: 1837412 Form Type: S-1 Registration of Securities Accession Number: 0001213900-21-051049 Submitted to the SEC: Fri Oct 01 2024 2:02:32 PM EST Accepted by the SEC: Fri Oct 01 2024 Industry: Commercial Physical And Biological Research External Resources: WebApr 6, 2024 · SOMALOGIC, INC. Capi. / Sales 2024. Capi. / Sales 2024. SomaLogic, Inc. is a protein biomarker discovery and clinical diagnostics company. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein. It offers SomaScan services, which … how does an object\u0027s mass affect its inertia

SomaLogic LinkedIn

WebTogether, Reynolds and company have already steered SomaLogic to the first major milestone marking the big strategic shift. As announced January 2024, SomaLogic has joined the “Digital Life ... WebIn the process, SomaLogic will receive up to $651 million in cash from CMLS II’s IPO earnings and common stock purchases from a handful of investors, bringing its total amount of cash available ... WebJul 27, 2011 · Agreement between SomaLogic and New England Biolabs enables the use of SOMAmer technology for the optimization of multiple PCR products. Boulder, CO and Ipswich, MA (July 27, 2011) - SomaLogic, Inc. and New England Biolabs, Inc. (NEB) announce today that they have entered into an exclusive licensing agreement whereby … photo acheteur

SomaLogic Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

SomaLogic S1/A IPO registration (amended) SLGC 12 Feb 21 14

WebMar 4, 2024 · SomaLogic has a market capitalisation of US$1.5b and burnt through US$27m last year, which is 1.7% of the company's market value. That means it could easily issue a few shares to fund more growth ... WebOct 31, 2024 · It consists of an SomaLogic SeqId truncated at the underscore, to remove its sequence version number. SomaId. Character. The SomaLogic identifier for the protein target. For the 1129 and 1310 assays, there is a one-to-one correspondence between SeqId and SomaId, but in theory there is a many-to-one correspondence. how does an object speed up or slow downWebMar 29, 2024 · SomaLogic will use the proceeds for technology development, new product offerings, expansion of its commercial infrastructure, and the pursuit of additional health system partnerships. Up to $50 million of the proceeds will be used to repurchase shares from legacy investor stockholders. how does an object\\u0027s position relate to work

"WebJan 11, 2024 · SomaLogic was one of three proteomics companies that merged with a special purpose acquisition company to become public.Now that the company has filed their first 10-Q, we now have some information to analyze. Just today, SomaLogic filed an 8-K with the SEC stating that revenue for the full year 2024 is expected to exceed $79 million, … " - Somalogic s1

Somalogic s1

SomaLogic Reports First Half of 2024 Financial Results - Yahoo!

WebSomaLogic, Boulder, Colorado. 305 likes · 3 talking about this · 40 were here. We scan the living data stream of human proteins with greater precision, sensitivity and scale than WebFeb 15, 2024 · SOMALOGIC, INC. : Financial news and information Stock SOMALOGIC, INC. Nasdaq: SLGC Nasdaq

Did you know?

WebMar 8, 2024 · SomaLogic's platform currently has assays to 7,000 proteins versus 3,000 for Olink. The two companies plan in the near future to expand their platforms to 10,000 and 4,500 proteins, respectively. "If you start with 7,000 and you get 50 percent [pQTL hits], that is more than if you got 50 percent from 3,000," Langenberg said. WebThroughout pharmaceutical development and academic/clinical research, Olink provides actionable insights through protein biomarkers across an extensive range of application areas, covering all aspects of human biology in health and disease. See all applications.

WebNov 10, 2024 · Figure S1. Distribution plots of the 65 cytokines targeted by the Discovery assay. Boxplot graphs showing relative fluorescence intensity (RFU; y axis) of the plasma samples (X) for ( a ), 60 of the 65 cytokines that were within the range of the external standards (from known low (S1) to high (S7) concentrations) while ( b ). 5 of the 65 … WebApr 11, 2024 · Comparatively, 66.8% of SomaLogic shares are owned by institutional investors. 6.3% of Luna Innovations shares are owned by insiders. Comparatively, 12.9% of SomaLogic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for …

WebMar 13, 2024 · SomaLogic Operating Co., Inc. has an overall rating of 3.0 out of 5, based on over 65 reviews left anonymously by employees. 45% of employees would recommend working at SomaLogic Operating Co., Inc. to a friend and … WebJul 11, 2024 · Quantum-Si looks to potentially be a leader in this burgeoning field, validation may take years to achieve however so this is a highly speculative stock and caution is warranted. The field of ...

WebSenior Account Manager, Life Sciences Sales, Boston Territory. SomaLogic, Inc. 3.5. Boston, MA 02101. Job Description: Within designated territory, develop and execute sales plans for SomaLogic’s SomaScan proteomic platform and SomaSignal Tests at …

WebIPO registration (amended), S-1/A SEC filing by SomaLogic on 12 Feb 21, 5:23pm photo access canberraWebMay 1, 2013 · However, the SomaLogic proteomics platform is ideally suited to this task. At the heart of the detection technology are SOMAmers (Slow Off-rate Modified Aptamers). They are modified DNA aptamers with high affinity (10 ∧ –9 to 10 ∧ –12 M) and high specificity for their cognate analytes. The assay is highly multiplexed, quantifying >1100 ... how does an object\u0027s length affect its pitchWebHere, we undertook an investigation of Alzheimer's disease cerebrospinal fluid (CSF) and plasma from the same subjects (n=18 control, n=18 AD) using three different proteomic platforms-SomaLogic SomaScan, Olink proximity extension assay, and tandem mass tag-based mass spectrometry-to assess which protein markers in these two biofluids may … photo accessories indiaWebThe source of the patient samples is described in Supporting Fig. S1. Sera were collected at the time of diagnosis (initial evaluation prior to or at the time of Kasai portoenterostomy) ... (SomaLogic, Inc., Boulder, CO) as described. See the Supporting Information for further details on materials and methods. Statistical Analysis. how does an object lose forceWebJun 25, 2024 · Abstract: Described herein are aptamers capable of binding to growth differentiation factor 11 (GDF11) protein; compositions comprising a GDF11 binding aptamer with a GDF11 protein; and methods of making and using the same. Type: Grant. Filed: November 23, 2015. Date of Patent: October 20, 2024. Assignee: SOMALOGIC, INC. how does an object\\u0027s mass affect its inertiaWebOxford Population Health and SomaLogic deliver 28 million proteomic data points on China Kadoorie Biobank samples BOULDER, Colo., March 13, 2024 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay on and delivered data for 4,000 plasma samples from the China Kadoorie Biobank (CKB), … photo accountingWebSep 8, 2024 · NEW YORK and BOULDER, Colo., Sept. 08, 2024 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the six months ended June 30, 2024. “Our strong first half performance reflects our team’s dedication and execution across key drivers of the business as well as the … photo accident kobe bryant